Overview

Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether BEMA Buprenorphine is safe in the treatment of chronic pain.
Phase:
Phase 3
Details
Lead Sponsor:
BioDelivery Sciences International
Endo Pharmaceuticals
Treatments:
Buprenorphine